3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
19
Ovarian Neoplasms
11
Neoplasms
7
Liposarcoma
7
Leiomyosarcoma
7
Neoplasm Metastasis
4
Sarcoma, Ewing
3
Breast Neoplasms
3
Solitary Fibrous Tumors
2
Sarcoma, Synovial
2
Rhabdomyosarcoma
2
Prostatic Neoplasms
2
Neoplasms by Site
2
Liposarcoma, Myxoid
2
Histiocytoma, Malignant Fibrous
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Wilms Tumor
1
Uterine Neoplasms
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Soft Tissue Neoplasms
1
Skin Diseases
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Alveolar Soft Part
1
Recurrent High Grade Meningioma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Ovarian Diseases
1
Interventions
Trabectedin
2
Doxorubicin
2
Dacarbazine
2
pazopanib
1
eribulin
1
Sunitinib
1
Nivolumab
1
Methotrexate
1
Ifosfamide
1
Epirubicin
1
Dasatinib
1
Cisplatin
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Solitary Fibrous Tumors
×
Trabectedin
×
Clear all
NCT04008238
2026-03-06
PIPER
Institut Bergonié
Phase NA
Completed
29 enrolled
NCT03023124
2024-12-09
STRADA
Italian Sarcoma Group
Phase 2
Completed
23 enrolled